Physician profile
Cynthia Marengo
NPI 1255821088
$4,022.58
in general payments reported to CMS, 2019-2025
9 companies · $1,654 in 2025
The $1,654 reported for 2025 was more than what 92% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $386 · 2022: $564 · 2023: $561 · 2024: $858 · 2025: $1,654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,961 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,960.70 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Cognition USA, INC. | $933.55 | 2025 | Zunveyl |
| Acadia Pharmaceuticals INC | $875.21 | 2021-2025 | Nuplazid |
| Neurocrine Biosciences, INC. | $820.08 | 2021-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $797.14 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Avanir Pharmaceuticals, INC. | $352.23 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $137.07 | 2023-2024 | Nuedexta, Rexulti |
| Sunovion Pharmaceuticals INC. | $46.75 | 2021 | |
| Sun Pharmaceutical Industries INC. | $42.96 | 2021-2022 | |
| Urovant Sciences INC | $17.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Marengo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.